Northern Trust’s Theriva Biologics TOVX Stock Holding History

Northern Trust’s Portfolio TOVX Stock Details TOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,059	Closed	-$6.26K	–	4453
2024 Q2	$6.26K	Sell	1,059 -5	-0.5%	-$44	﹤0.01%	4401
2024 Q1	$12.5K	Hold	1,064	–	–	﹤0.01%	4374
2023 Q4	$11.4K	Hold	1,064	–	–	﹤0.01%	4412
2023 Q3	$14.3K	Hold	1,064	–	–	﹤0.01%	4370
2023 Q2	$26.6K	Sell	1,064 -364	-25%	-$6.41K	﹤0.01%	4349
2023 Q1	$24.9K	Hold	1,428	–	–	﹤0.01%	4407
2022 Q4	$16.2K	Hold	1,428	–	–	﹤0.01%	4523
2022 Q3	$35K	Buy	1,428 +105	+8%	+$4.03K	﹤0.01%	4421
2022 Q2	$70K	Sell	1,323 -23	-2%	-$1.32K	﹤0.01%	4303
2022 Q1	$96K	Buy	1,346 +364	+37%	+$24.8K	﹤0.01%	4351
2021 Q4	$67K	Hold	982	–	–	﹤0.01%	4538
2021 Q3	$113K	Hold	982	–	–	﹤0.01%	4371
2021 Q2	$148K	Sell	982 -4	-0.4%	-$573	﹤0.01%	4252
2021 Q1	$168K	Buy	986 +931	+1,693%	+$184K	﹤0.01%	4155
2020 Q4	$5K	Sell	55 -59	-52%	-$5.17K	﹤0.01%	4362
2020 Q3	$14K	Buy	114 +32	+39%	+$4.27K	﹤0.01%	4245
2020 Q2	$11K	Hold	82	–	–	﹤0.01%	4211
2020 Q1	$7K	Buy	+82	New	+$9.34K	﹤0.01%	4174
2018 Q3	–	Sell	-20	Closed	-$41K	–	4334
2018 Q2	$41K	Hold	20	–	–	﹤0.01%	4144
2018 Q1	$55K	Hold	20	–	–	﹤0.01%	4067
2017 Q4	$87K	Hold	20	–	–	﹤0.01%	3997
2017 Q3	$161K	Hold	20	–	–	﹤0.01%	3850
2017 Q2	$97K	Sell	20 -96	-83%	-$478K	﹤0.01%	3984
2017 Q1	$642K	Buy	116 +8	+7%	+$55.8K	﹤0.01%	3476
2016 Q4	$722K	Buy	108 +13	+14%	+$133K	﹤0.01%	3434
2016 Q3	$1.44M	Buy	95 +1	+1%	+$15K	﹤0.01%	3219
2016 Q2	$1.48M	Buy	94 +81	+623%	+$1.52M	﹤0.01%	3189
2016 Q1	$267K	Buy	13 +1	+8%	+$15K	﹤0.01%	3636
2015 Q4	$247K	Hold	12	–	–	﹤0.01%	3696
2015 Q3	$245K	Buy	12 +3	+33%	+$73.8K	﹤0.01%	3676
2015 Q2	$229K	Sell	9 -2	-18%	-$40.1K	﹤0.01%	3754
2015 Q1	$211K	Buy	11 +4	+57%	+$71.4K	﹤0.01%	3853
2014 Q4	$86K	Hold	7	–	–	﹤0.01%	4002
2014 Q3	$105K	Hold	7	–	–	﹤0.01%	4009
2014 Q2	$102K	Hold	7	–	–	﹤0.01%	4007
2014 Q1	$151K	Buy	7 +2	+40%	+$41.4K	﹤0.01%	3853
2013 Q4	$69K	Buy	5 +1	+25%	+$12.6K	﹤0.01%	3932
2013 Q3	$59K	Hold	4	–	–	﹤0.01%	3912
2013 Q2	$60K	Buy	+4	New	+$54.7K	﹤0.01%	3899

Other funds holding TOVX

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust's TOVX Position: Q3 2024 in Review

Northern Trust sold out of Theriva Biologics (TOVX) in Q3 2024, closing a stake of 1,059 shares — an estimated $6.26K sold.

Northern Trust first reported a position in TOVX in Q2 2013 and held it in 39 quarters. The position peaked at $1.48M in Q2 2016. 18 funds tracked by Wall St. Rank hold TOVX as of Q3 2024.

Northern Trust reported no remaining Theriva Biologics position as of Q3 2024 after selling out during the quarter.
Northern Trust sold 1,059 Theriva Biologics shares in Q3 2024, an estimated $6.26K.
Northern Trust first reported a position in Theriva Biologics in Q2 2013 and held it in 39 quarters.
Northern Trust's Theriva Biologics position peaked at $1.48M in Q2 2016.
18 funds tracked by Wall St. Rank held Theriva Biologics as of Q3 2024.

Based on Northern Trust's 13F filing for Q3 2024, filed 13 Nov 2024.